NCT02699333

Brief Summary

Microscopic colitis is a common cause of watery diarrhea, particularly in the elderly. Although the incidence is comparable to ulcerative colitis and Crohn's disease, the etiology is unknown. Understanding the etiology of microscopic colitis is an important step in developing logical interventions to decrease the burden from microscopic colitis. This research could provide critical insights into the etiology of this poorly studied condition.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
346

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started May 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 23, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 4, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

May 1, 2016

Completed
4.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 24, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 24, 2020

Completed
Last Updated

February 21, 2021

Status Verified

February 1, 2021

Enrollment Period

4.7 years

First QC Date

February 23, 2016

Last Update Submit

February 19, 2021

Conditions

Outcome Measures

Primary Outcomes (1)

  • Microscopic Colitis

    Microscopic colitis defined by increased lymphocytes or collagen

    Day 1

Study Arms (2)

Microscopic colitis cases

Patients found to have microscopic colitis based on colonic biopsies.

Controls

Patients who meet eligibility requirements but do not have microscopic colitis on biopsy.

Eligibility Criteria

Age35 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who undergo colonoscopy for diarrhea at the University of North Carolina

You may qualify if:

  • Colonoscopy for diarrhea

You may not qualify if:

  • Fewer than 4 loose bowel movements per day.
  • Failure to visualize the entire colon to the cecum or preparation less than good or excellent.
  • Age under 35 years. There will be no upper age limit.
  • Inability to understand and cooperate with the interview.
  • Indication for colonoscopy other than diarrhea.
  • Prior history of inflammatory bowel disease (Crohn's disease or ulcerative colitis).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of North Carolina

Chapel Hill, North Carolina, 27599-7555, United States

Location

Biospecimen

Retention: SAMPLES WITH DNA

40 ml of blood centrifuged and separated into plasma, buffy coat and red blood cells. A serum separator tube will be used to collect an additional 10 ml of blood for serum. During colonoscopy, four mucosal biopsies will be obtained from normal appearing mucosa in the ascending colon, transverse colon, and descending/sigmoid colon during the withdrawal phase of the exam from each patient (12 research biopsies). To improve orientation 2 biopsies from each segment will be flattened onto filter paper using a forceps and placed together into fixative. The remaining 2 biopsies from each area will be rinsed in sterile PBS to ensure there is no contamination with fecal bacteria prior to freezing in liquid nitrogen.

MeSH Terms

Conditions

Colitis, Microscopic

Condition Hierarchy (Ancestors)

ColitisGastroenteritisGastrointestinal DiseasesDigestive System DiseasesColonic DiseasesIntestinal Diseases

Study Officials

  • Robert S. Sandler, MD

    University of North Carolina, Chapel Hill

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 23, 2016

First Posted

March 4, 2016

Study Start

May 1, 2016

Primary Completion

December 24, 2020

Study Completion

December 24, 2020

Last Updated

February 21, 2021

Record last verified: 2021-02

Locations